← Evidence map

Observational studyMedical science monitor : international medical journal of experimental and clinical research2022

A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania.

Xenia Bacinschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35787600